200,000+ products from a single source!

sales@angenechem.com

Home > Pyridines > 144141-97-9

144141-97-9

144141-97-9 | 12-Oxa-2,7,10-triazatridecanoic acid, 5-hydroxy-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-13-(2-pyridinyl)-, 3-pyridinylmethyl ester, (3S,5S,6S,9S)-

CAS No: 144141-97-9 Catalog No: AG001J00 MDL No:

Product Description

Catalog Number:
AG001J00
Chemical Name:
12-Oxa-2,7,10-triazatridecanoic acid, 5-hydroxy-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-13-(2-pyridinyl)-, 3-pyridinylmethyl ester, (3S,5S,6S,9S)-
CAS Number:
144141-97-9
Molecular Formula:
C37H43N5O6
Molecular Weight:
653.7672
IUPAC Name:
pyridin-2-ylmethyl N-[(2S)-1-[[(2S,3S,5S)-3-hydroxy-1,6-diphenyl-5-(pyridin-3-ylmethoxycarbonylamino)hexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
InChI:
InChI=1S/C37H43N5O6/c1-26(2)34(42-37(46)48-25-30-17-9-10-19-39-30)35(44)41-32(21-28-14-7-4-8-15-28)33(43)22-31(20-27-12-5-3-6-13-27)40-36(45)47-24-29-16-11-18-38-23-29/h3-19,23,26,31-34,43H,20-22,24-25H2,1-2H3,(H,40,45)(H,41,44)(H,42,46)/t31-,32-,33-,34-/m0/s1
InChI Key:
SSIBMWPFXYSVEK-CUPIEXAXSA-N
SMILES:
O=C(N[C@H](C[C@@H]([C@@H](NC(=O)[C@H](C(C)C)NC(=O)OCc1ccccn1)Cc1ccccc1)O)Cc1ccccc1)OCc1cccnc1
UNII:
145DTK1W1Y

Properties

Complexity:
957  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
4  
Defined Bond Stereocenter Count:
0
Exact Mass:
653.321g/mol
Formal Charge:
0
Heavy Atom Count:
48  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
653.78g/mol
Monoisotopic Mass:
653.321g/mol
Rotatable Bond Count:
18  
Topological Polar Surface Area:
152A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5  

Literature

Title Journal
Quantitative structure-activity relationship of some HIV-1 protease inhibitors: a Fujita-Ban type analysis. Journal of enzyme inhibition 20010101
Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Bioorganic & medicinal chemistry letters 19981215
Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. Journal of medicinal chemistry 19980212
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 19950406
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proceedings of the National Academy of Sciences of the United States of America 19950328
Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323. Antimicrobial agents and chemotherapy 19940701

Related Products

© 2019 Angene International Limited. All rights Reserved.